Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Maurer

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Research Communications|October 3, 2022
BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcomaLisa M Maurer, Jessica D Daley, Elina Mukherjee, et al.
The Journal of Clinical Investigation|April 15, 2025
A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphomaHeejae Kang, Lisa M Maurer, Jing Cheng, et al.
The Journal of Clinical Investigation|January 22, 2020
GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoproteinJing Cheng, Linda R Klei, Nathaniel E Hubel, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppressionJuliana Hofstätter Azambuja, Saigopalakrishna S Yerneni, Lisa M Maurer, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Research Communications|October 3, 2022
BRCA1-associated RING domain-1 (BARD1) loss and GBP1 expression enhance sensitivity to DNA damage in Ewing sarcomaLisa M Maurer, Jessica D Daley, Elina Mukherjee, et al.
The Journal of Clinical Investigation|April 15, 2025
A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphomaHeejae Kang, Lisa M Maurer, Jing Cheng, et al.
The Journal of Clinical Investigation|January 22, 2020
GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoproteinJing Cheng, Linda R Klei, Nathaniel E Hubel, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppressionJuliana Hofstätter Azambuja, Saigopalakrishna S Yerneni, Lisa M Maurer, et al.
Pageof 2